CytoDyn (CYDY) Operating Leases (2019 - 2025)

CytoDyn's (CYDY) quarterly Operating Leases came in at $34000.0 in Q1 2025, down 80.68% YoY from $176000.0 in Q1 2024, and down 50.72% on a QoQ basis from $69000.0 in Q4 2024.

CytoDyn (CYDY) Operating Leases (2019 - 2025) Analysis & Trends

CytoDyn (CYDY) has 7 years of Operating Leases data on file, last reported at $34000.0 in Q1 2025.

  • Quarterly Operating Leases fell 80.68% year-over-year to $34000.0 in Q1 2025, while the trailing twelve-month figure through Feb 2025 was $34000.0 (down 80.68% YoY) and the FY2024 annual result came in at $141000.0, down 50.18% from the prior year.
  • Operating Leases fell to $34000.0 in Q1 2025, from $69000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $588000.0 in Q1 2021 to a low of $34000.0 in Q1 2025.
  • A 5-year average of $314352.9 and a median of $318000.0 in 2023 frame the typical range for Operating Leases.
  • Annual changes were most pronounced in 2021 — Operating Leases jumped 776.19% — and 2025, when it sank 80.68%.
  • Tracing CYDY's Operating Leases over 5 years: stood at $486000.0 in 2021, then slipped by 27.37% to $353000.0 in 2022, then plunged by 40.23% to $211000.0 in 2023, then tumbled by 67.3% to $69000.0 in 2024, then tumbled by 50.72% to $34000.0 in 2025.
  • The last three Operating Leases figures came in at $34000.0 (Q1 2025), $69000.0 (Q4 2024), and $105000.0 (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 CytoDyn 258.01 Mn 258.01 Mn -

Historic Data

Download Data
DateValue
Feb 28, 2025 34,000.00
Nov 30, 2024 69,000.00
Aug 31, 2024 105,000.00
May 31, 2024 141,000.00
Feb 29, 2024 176,000.00
Nov 30, 2023 211,000.00
Aug 31, 2023 247,000.00
May 31, 2023 283,000.00
Feb 28, 2023 318,000.00
Nov 30, 2022 353,000.00
Aug 31, 2022 387,000.00
May 31, 2022 422,000.00
Feb 28, 2022 453,000.00
Nov 30, 2021 486,000.00
Aug 31, 2021 519,000.00
May 31, 2021 552,000.00
Feb 28, 2021 588,000.00
Nov 30, 2020 286,000.00
Aug 31, 2020 314,000.00
May 31, 2020 63,000.00